Comparison between Allchem Lifescience IPO and Ivalue Infosolutions IPO.
Allchem Lifescience IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ivalue Infosolutions IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Allchem Lifescience IPO is up to ₹0.00 Cr whereas the issue size of the Ivalue Infosolutions IPO is up to ₹560.29 Cr. The final issue price of Allchem Lifescience IPO is and of Ivalue Infosolutions IPO is ₹299.00 per share.
| Allchem Lifescience IPO | Ivalue Infosolutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹284.00 per share | |
| Issue Price (Upper) | ₹299.00 per share | |
| Issue Price (Final) | ₹299.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 50 shares | |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 71,55,000 shares | 1,87,38,958 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹560.29 Cr |
| Issue Size Total | 0 shares | 1,87,38,958 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹560.29 Cr |
Allchem Lifescience IPO opens on , while Ivalue Infosolutions IPO opens on Sep 18, 2025. The closing date of Allchem Lifescience IPO and Ivalue Infosolutions IPO is , and Sep 22, 2025, respectively.
| Allchem Lifescience IPO | Ivalue Infosolutions IPO | |
|---|---|---|
| Anchor Bid Date | Sep 17, 2025 | |
| Issue Open | Sep 18, 2025 | |
| Issue Close | Sep 22, 2025 | |
| Basis Of Allotment (Tentative) | Sep 23, 2025 | |
| Initiation of Refunds (Tentative) | Sep 24, 2025 | |
| Credit of Share (Tentative) | Sep 24, 2025 | |
| Listing date (Tentative) | Sep 25, 2025 | |
| Anchor Lockin End date 1 | Oct 22, 2025 | |
| Anchor Lockin End date 2 | Dec 21, 2025 |
Allchem Lifescience IPO P/E ratio is , as compared to Ivalue Infosolutions IPO P/E ratio of 18.77.
| Allchem Lifescience IPO | Ivalue Infosolutions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)Ivalue Infosolutions Ltd.'s revenue increased by 19% and profit after tax (PAT) rose by 21% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 39.92 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 32.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 18.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1600.84 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.33% | 21.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 22.87% | 28.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.06 | ₹15.93 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 34.33% | 22.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Allchem Lifescience IPO Retail Individual Investors (RII) are offered while in Ivalue Infosolutions IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Allchem Lifescience IPO and 37,47,792 shares in Ivalue Infosolutions IPO.
| Allchem Lifescience IPO | Ivalue Infosolutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 56,21,686 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 37,47,792 shares | |
| NII | 28,10,844 shares | |
| RII | 65,58,636 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 1,87,38,958 shares |
Allchem Lifescience IPO subscribed in total, whereas Ivalue Infosolutions IPO subscribed 1.82x.
| Allchem Lifescience IPO | Ivalue Infosolutions IPO | |
|---|---|---|
| QIB (times) | 3.18x | |
| NII (times) | 1.26x | |
| Big NII (times) | 1.04x | |
| Small NII (times) | 1.71x | |
| RII (times) | 1.28x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.82x |
